scPharmaceuticals Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for scPharmaceuticals stock had an average target of $12, with a low estimate of $6.00 and a high estimate of $18.

Price Target: $12 (+111.64%)

Analyst Consensus: Buy

Price Target

Target	Low	Average	Median	High
Price	$6.00	$12	n/a	$18
Change	+5.82%	+111.64%	n/a	+217.46%

Analyst Ratings

The average analyst rating for scPharmaceuticals stock from 3 stock analysts was "Buy". This means that analysts believed this stock was likely to outperform the market over the next twelve months.

Recommendation Trends

No data available

Rating	Oct 2026
Strong Buy	n/a
Buy	n/a
Hold	n/a
Sell	n/a
Strong Sell	n/a
Total	n/a

Financial Forecast

Revenue This Year

74.23M

from 36.33M

104.30%

from 36.33M

Revenue Next Year

130.68M

from 74.23M

76.06%

from 74.23M

EPS This Year

-1.11

from -1.91

EPS Next Year

-0.16

from -1.11

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	13.59M	36.33M	74.23M	130.68M
Revenue Growth	-	-	-	-	167.29%	104.30%	76.06%
EPS	-1.31	-1.02	-1.30	-1.42	-1.91	-1.11	-0.16
No. Analysts	-	-	-	-	-	6	6

Revenue Forecast

Revenue	2025	2026
High	78.8M	157.5M
Avg	74.2M	130.7M
Low	69.6M	117.2M

Revenue Growth

Revenue Growth	2025	2026
High	116.8%	112.2%
Avg	104.3%	76.1%
Low	91.5%	57.9%

EPS Forecast

EPS	2025	2026
High	-1.10	0.21
Avg	-1.11	-0.16
Low	-1.10	-0.33

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-